Families of children and adults living with a repaired heart defect got a recall notice this month that sounds far worse than it is, and the distinction is worth getting right.
Medtronic has removed certain lots of the Harmony Delivery Catheter System from the market because the tip of the catheter can come off during the procedure. The FDA has identified the action as its most serious recall type, meaning continued use could cause serious injury or death.
The valve itself is not being recalled. The agency's notice states plainly that "no additional actions are required for patients with a successfully implanted Harmony TPV," and that those patients should continue with their practice's standard follow-up.
Two Devices, One Procedure, Very Different Implications
The confusion is understandable, because both parts share the Harmony name and both are used in the same catheterization lab appointment.
The Harmony transcatheter pulmonary valve is the implant. It is a replacement valve placed inside the pathway that carries blood from the heart to the lungs, and it stays in the patient permanently. The FDA approved it in 2021 as the first device of its kind for patients with congenital heart disease, offering a nonsurgical option for a leaky right ventricular outflow tract.
The Harmony Delivery Catheter System is the tool. It is a single-use, over-the-wire catheter that carries the valve through the blood vessels and into position, and it comes back out at the end of the case. Once the procedure is finished, the delivery catheter is gone.
The recall is entirely about the tool.
The Specific Failure and What It Would Mean During a Case
According to the FDA notice, certain lots of the delivery catheter have an increased risk of the distal tip detaching. If that happens during an implant, a second intervention would be needed to retrieve the tip, either through the blood vessels or surgically.
The agency lists additional potential risks including a longer procedure, longer exposure to fluoroscopy imaging, vessel blockage, tissue damage, leaking of the pulmonary valve, embolism, and bleeding.
As of May 14, Medtronic had not reported any serious injuries or deaths associated with the issue. A Medtronic spokesperson told MedTech Dive that the problem is limited to certain delivery systems and does not involve the valve, and that the underlying manufacturing problem has been resolved so future shipments will not be affected. That same report put the action at more than 1,800 units distributed worldwide, based on an FDA enforcement report.
Medtronic sent affected customers a letter in late May instructing them to immediately quarantine and return affected product, to share the notification with implanting physicians and their teams, and to notify any facility that received forwarded product.
The Households This Actually Reaches
The Harmony system is indicated for pediatric and adult patients with severe pulmonary regurgitation who have a native or surgically repaired right ventricular outflow tract and who would otherwise be candidates for surgical valve replacement. In practice, that means people born with tetralogy of Fallot and related congenital defects, many of whom had open-heart surgery in infancy and are now facing a leaking pulmonary valve years or decades later.
That is a comparatively small population, but it is a population that has spent a lifetime tracking device news. For a parent whose teenager had a Harmony valve placed last year, the correct takeaway is that nothing changes. No imaging, no unscheduled visit, no medication change.
For a family with a procedure on the calendar, the useful question is inventory. Ask whether the hospital has checked its Harmony delivery catheter stock against the affected lot numbers, which the FDA publishes in a downloadable list linked from its recall notice, and whether unaffected supply is on hand for the scheduled date. Medtronic has said the manufacturing issue is resolved for new production.
What should not happen is a family deciding on their own to postpone a needed valve replacement. Severe pulmonary regurgitation left untreated carries its own risks to the right side of the heart, and the timing of intervention is a decision for the congenital cardiology team.
Where the Open Questions Remain
Several things are not yet settled. The FDA notice does not state how many of the affected catheters were actually used before the recall, or how many procedures were completed with lots later identified as affected. The absence of reported serious injuries as of mid-May reflects what the manufacturer had reported by that date, not a guarantee that no case will surface.
This is also not the first Harmony delivery catheter action. Medtronic recalled the Harmony delivery catheter in 2022 over a risk of breakage during use and relaunched the system after working with the FDA, a history that reasonably prompts questions about manufacturing controls on the delivery hardware.
Patients and clinicians who experience problems can report them to the FDA through MedWatch. U.S. customers with questions about the recall can contact Medtronic directly using the number listed in the agency notice. MedicalDaily will monitor the FDA recall page for any updates to injury reports, lot list revisions, or a change in the scope of the action.
The newest confirmed fact is that certain Harmony delivery catheter lots have been pulled over a tip detachment risk, with no serious injuries or deaths reported as of mid-May. The group most affected is patients with scheduled Harmony valve procedures, not those already implanted. The most reasonable action is to ask the care team about hospital inventory. The central uncertainty is how many affected units reached procedures before the removal.
Frequently Asked Questions
Is my implanted Harmony valve being recalled? No. The FDA notice states that no additional actions are required for patients with a successfully implanted Harmony transcatheter pulmonary valve. Continue with your normal follow-up schedule.
What was recalled? Certain lots of the Harmony Delivery Catheter System, the single-use catheter that carries the valve into position during the implant procedure and is removed at the end of the case.
What could go wrong with the catheter? The tip can detach during the implant. Retrieving it would require a second intervention through the blood vessels or surgery. The FDA also lists longer procedure and imaging time, vessel blockage, tissue damage, valve leakage, embolism, and bleeding as potential risks.
Has anyone been hurt? Medtronic reported no serious injuries and no deaths associated with this issue as of May 14, 2026.
Who receives a Harmony valve? Pediatric and adult patients with severe pulmonary regurgitation who have a native or surgically repaired right ventricular outflow tract and are candidates for surgical pulmonary valve replacement. Many were born with congenital heart defects such as tetralogy of Fallot.
I have a procedure scheduled. What should I ask? Ask whether the hospital has checked its delivery catheter inventory against the FDA's affected lot list and whether unaffected supply is available for your date. Do not postpone a needed procedure without your cardiology team's input.
Is this the first Harmony catheter recall? No. Medtronic recalled the Harmony delivery catheter in 2022 over a breakage risk and later relaunched the system after working with the FDA.
